The Cancer Institute Hospital Of JFCR /ID# 268342

Koto-ku, Tokyo 135-8550

1 studies enrolling now · 1 studies all time

What they study most

Multiple Myeloma

Studies at this site

• Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma — Recruiting now